Viral shedding prolongation in a kidney transplant patient with COVID-19 pneumonia.
作者信息
Man Zhang, Jing Zhang, Huibo Shi, Bin Liu, Fanjun Zeng
机构信息
Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Key Laboratory of Organ Transplantation, Ministry of Education, NHC Key Laboratory of Organ Transplantation, Key Laboratory of Organ Transplantation, Chinese Academy of Medical Sciences, Wuhan, China.
出版信息
Am J Transplant. 2020 Sep;20(9):2626-2627. doi: 10.1111/ajt.15996. Epub 2020 Jun 7.
Abstract
摘要
相似文献
1
Viral shedding prolongation in a kidney transplant patient with COVID-19 pneumonia.一名新冠肺炎肺炎肾移植患者的病毒脱落延长
Am J Transplant. 2020 Sep;20(9):2626-2627. doi: 10.1111/ajt.15996. Epub 2020 Jun 7.
2
Novel coronavirus 2019 pneumonia in a kidney transplant recipient.肾移植受者 2019 年新型冠状病毒肺炎。
Am J Transplant. 2020 Sep;20(9):2599-2601. doi: 10.1111/ajt.15999. Epub 2020 Jun 12.
3
Kidney transplantation with presymptomatic COVID-19-positive surgeon.由无症状新冠病毒检测呈阳性的外科医生进行肾移植手术。
Am J Transplant. 2020 Sep;20(9):2624-2625. doi: 10.1111/ajt.15971. Epub 2020 Jun 9.
4
The impact of COVID-19 on kidney transplantation.COVID-19 对肾移植的影响。
Nat Rev Nephrol. 2020 Oct;16(10):568-569. doi: 10.1038/s41581-020-00340-z.
5
A kidney transplant recipient with nausea, vomiting, and diarrhea after a recent COVID-19 exposure.一名肾移植受者近期接触新冠病毒后出现恶心、呕吐和腹泻症状。
Am J Transplant. 2020 Sep;20(9):2618-2620. doi: 10.1111/ajt.16184.
6
Cardiac and Pulmonary Transplant Considerations During COVID-19 Pandemic.2019冠状病毒病大流行期间心脏和肺移植的考量因素
Innovations (Phila). 2020 Jul/Aug;15(4):314-316. doi: 10.1177/1556984520937007. Epub 2020 Jun 30.
7
Abdominal fluid samples (negative for SARS-CoV-2) from a critically unwell patient with respiratory COVID-19.一名患有呼吸道新型冠状病毒肺炎的危重症患者的腹腔积液样本（严重急性呼吸综合征冠状病毒2检测呈阴性）
Br J Surg. 2020 Jul;107(8):e259-e260. doi: 10.1002/bjs.11713. Epub 2020 May 26.
8
Preliminary data on outcomes of SARS-CoV-2 infection in a Spanish single center cohort of kidney recipients.西班牙单中心肾移植受者队列中新型冠状病毒肺炎感染结局的初步数据。
Am J Transplant. 2020 Oct;20(10):2958-2959. doi: 10.1111/ajt.15970. Epub 2020 May 27.
9
Colorectal cancer surgery during the COVID-19 pandemic.2019冠状病毒病大流行期间的结直肠癌手术
Br J Surg. 2020 Jul;107(8):e267. doi: 10.1002/bjs.11734. Epub 2020 Jun 3.
10
Immunosuppressive therapy maintenance in a kidney transplant recipient with SARS-CoV-2 pneumonia: A case report.肾移植受者 SARS-CoV-2 肺炎的免疫抑制治疗维持：一例报告。
Am J Transplant. 2020 Jul;20(7):1922-1924. doi: 10.1111/ajt.15920. Epub 2020 May 8.
引用本文的文献
1
The effectiveness of nirmatrelvir/ritonavir regimen in hospitalized renal transplant patients with prolonged COVID-19 infection: a multicenter clinical experience.奈玛特韦/利托那韦方案对新冠病毒感染迁延不愈的住院肾移植患者的有效性：一项多中心临床经验
Ren Fail. 2024 Dec;46(2):2385724. doi: 10.1080/0886022X.2024.2385724. Epub 2024 Sep 16.
2
New Scenarios in Heart Transplantation and Persistency of SARS-CoV-2 (Case Report).心脏移植的新情况与新型冠状病毒2的持续性（病例报告）
Life (Basel). 2023 Jul 13;13(7):1551. doi: 10.3390/life13071551.
3
Covid-19 in kidney transplant recipients with immunosuppressive therapy.接受免疫抑制治疗的肾移植受者中的新冠病毒 19 感染情况。
Caspian J Intern Med. 2022;13(Suppl 3):161-172. doi: 10.22088/cjim.12.4.509.
4
RT- PCR testing of upper respiratory tract samples for diagnosis of SARS-CoV-2: Between justification and overestimation, a multi-center international study.对呼吸道样本进行 RT-PCR 检测以诊断 SARS-CoV-2：一项多中心国际研究，合理性与高估之间。
Travel Med Infect Dis. 2022 Jul-Aug;48:102334. doi: 10.1016/j.tmaid.2022.102334. Epub 2022 Apr 22.
5
Tacrolimus-resistant SARS-CoV-2-specific T cell products to prevent and treat severe COVID-19 in immunosuppressed patients.用于预防和治疗免疫抑制患者严重 COVID-19 的抗他克莫司 SARS-CoV-2 特异性 T 细胞产品。
Mol Ther Methods Clin Dev. 2022 Jun 9;25:52-73. doi: 10.1016/j.omtm.2022.02.012. Epub 2022 Feb 26.
6
An Update on the Status of Vaccine Development for SARS-CoV-2 Including Variants. Practical Considerations for COVID-19 Special Populations.SARS-CoV-2 疫苗开发现状及变异株更新。COVID-19 特殊人群的实用考虑因素。
Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296211056648. doi: 10.1177/10760296211056648.
7
Risk factors associated with prolonged viral clearance in patients with a refractory course of COVID-19: a retrospective study.新冠病毒肺炎难治性病程患者病毒清除延迟的相关危险因素：一项回顾性研究
PeerJ. 2021 Nov 23;9:e12535. doi: 10.7717/peerj.12535. eCollection 2021.
8
Monoclonal antibody treatment for COVID-19 in solid organ transplant recipients.COVID-19 单克隆抗体治疗在实体器官移植受者中的应用。
Transpl Infect Dis. 2022 Feb;24(1):e13759. doi: 10.1111/tid.13759. Epub 2021 Dec 7.
9
Kidney transplant recipients' attitudes toward COVID-19 vaccination and barriers and enablers to vaccine acceptance.肾移植受者对 COVID-19 疫苗接种的态度以及对疫苗接种的接受的障碍和促进因素。
Transpl Infect Dis. 2022 Feb;24(1):e13749. doi: 10.1111/tid.13749. Epub 2021 Nov 3.
10
SARS-CoV-2 in Solid Organ Transplant Recipients: A Structured Review of 2020.SARS-CoV-2 在实体器官移植受者中的研究进展：2020 年的系统综述
Transplant Proc. 2021 Oct;53(8):2421-2434. doi: 10.1016/j.transproceed.2021.08.019. Epub 2021 Aug 16.
本文引用的文献
1
Coronavirus Disease 2019 Pneumonia in Immunosuppressed Renal Transplant Recipients: A Summary of 10 Confirmed Cases in Wuhan, China.新型冠状病毒肺炎合并免疫抑制的肾移植受者肺炎：中国武汉 10 例确诊病例总结
Eur Urol. 2020 Jun;77(6):748-754. doi: 10.1016/j.eururo.2020.03.039. Epub 2020 Apr 18.
2
Stability issues of RT-PCR testing of SARS-CoV-2 for hospitalized patients clinically diagnosed with COVID-19.SARS-CoV-2 的 RT-PCR 检测在临床上诊断为 COVID-19 的住院患者中的稳定性问题。
J Med Virol. 2020 Jul;92(7):903-908. doi: 10.1002/jmv.25786. Epub 2020 Apr 5.
3
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
4
Detection of SARS-CoV-2 in Different Types of Clinical Specimens.SARS-CoV-2 在不同类型临床标本中的检测。
JAMA. 2020 May 12;323(18):1843-1844. doi: 10.1001/jama.2020.3786.
5
Prolonged respiratory viral shedding in transplant patients.移植患者呼吸道病毒长期排毒现象。
Transpl Infect Dis. 2014 Feb;16(1):165-9. doi: 10.1111/tid.12167. Epub 2013 Dec 2.
Zotero 插件